Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes.
about
Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspectiveGender differences in murine pulmonary responses elicited by cellulose nanocrystalsVirtual Experiments Enable Exploring and Challenging Explanatory Mechanisms of Immune-Mediated P450 Down-RegulationAssessment of Disease-Related Therapeutic Protein Drug-Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative ColitisHepatic gene expression profiling reveals protective responses in Atlantic salmon vaccinated against furunculosisEmergency open cholecystectomy is associated with markedly lower incidence of postoperative nausea and vomiting (PONV) than elective open cholecystectomy: a retrospective cohort studyThe transcriptional regulation of the human CYP2C genesDisease-Drug Interaction of Sarilumab and Simvastatin in Patients with Rheumatoid Arthritis.Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.The correlation between the expression of genes involved in drug metabolism and the blood level of tacrolimus in liver transplant receiptsDEC1 binding to the proximal promoter of CYP3A4 ascribes to the downregulation of CYP3A4 expression by IL-6 in primary human hepatocytesPharmacokinetics of mycophenolic acid in patients with lupus nephritis.Pregnane X receptor is required for interleukin-6-mediated down-regulation of cytochrome P450 3A4 in human hepatocytes.A clinical therapeutic protein drug-drug interaction study: coadministration of denosumab and midazolam in postmenopausal women with osteoporosis.Inflammation is associated with voriconazole trough concentrations.Transcriptional regulation of the human P450 oxidoreductase gene: hormonal regulation and influence of promoter polymorphisms.Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosisSelective role for tumor necrosis factor-α, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen.Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokineticsModulation of hepatic cytochrome P450s by Citrobacter rodentium infection in interleukin-6- and interferon-{gamma}-null miceImmunological response as a source to variability in drug metabolism and transport.The role of the immune system in nevirapine-induced subclinical liver injury of a rat model.Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patientsMolecular mechanisms of genetic variation and transcriptional regulation of CYP2C19.Maternal obesity alters feto-placental cytochrome P4501A1 activity.Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model.Pharmacokinetic and pharmacodynamic properties of canakinumab, a human anti-interleukin-1β monoclonal antibodyProfiling of hepatic clearance pathways of Pittsburgh compound B and human liver cytochrome p450 phenotyping.CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotypeEffects of commonly used excipients on the expression of CYP3A4 in colon and liver cells.Regulation of hepatic cytochrome P450 expression in mice with intestinal or systemic infections of citrobacter rodentium.Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing.Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures.The effect of ZnO nanoparticles on liver function in ratsHepatic cytochrome P450s, phase II enzymes and nuclear receptors are downregulated in a Th2 environment during Schistosoma mansoni infection.Long-term virus-induced alterations of CYP3A-mediated drug metabolism: a look at the virology, immunology and molecular biology of a multi-faceted problem.Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines.Selective effects of a therapeutic protein targeting tumor necrosis factor-alpha on cytochrome P450 regulation during infectious colitis: Implications for disease-dependent drug-drug interactions.4β-Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State.Interleukin-6 and cytochrome-P450, reason for concern?
P2860
Q27009221-7F88777E-D9BB-414D-B1B1-957D7F79EEA9Q28396338-A3E32EB3-3EC7-4A15-9F1D-022029C8A87FQ28552467-A709EE07-03C2-48A4-B8B0-C395127B3E84Q28597396-B03E8497-6909-491C-8F3F-0AAF4FB0C1BAQ33514116-586E4C6C-496A-4F12-8398-434D5B5DD2E2Q33530925-A6C045FB-02C2-4F7D-BCAD-FEBDF566F35CQ33597311-5ECD979B-3C7E-43FE-BABC-F5F69437AE58Q33658743-0F1970CC-0A30-4EFE-A49F-49052878592BQ33714587-0EDCAE79-D4D9-4417-A9BB-3C3A17C4E268Q33793971-23F510D8-38EE-42B4-9E59-1B1161FA5E63Q33869682-0252FD6C-ED46-4C84-8099-DD8A144E063EQ33984216-0DEE05DD-22B1-4D87-A7B9-5465934F64BCQ34101899-1B008BD2-612B-4E94-BFF8-0C59395EEC75Q34286862-38D1C647-15BB-44C7-B7BC-C7468AD037DBQ34597394-93F014E7-19E7-4BAD-B556-AFC3F33B9681Q34856488-C85A592D-4E16-479E-9158-4774060BC78DQ34994708-0F9CE5C5-F5C3-4246-BE9B-5E06EB7B91B9Q35072031-ACE97BCA-F5A1-4ACE-895F-06B18D0CD982Q35114057-A89DFCF4-956B-46C9-B45F-C859C95F16DFQ35454343-3FFAE781-AD1E-4065-A5F6-D66B04D3E697Q35749503-DB7697D3-CC7F-465E-9202-6FEE85B5FE40Q36200176-DE678B1C-EDBC-4140-BF4C-226C6D743F55Q36243677-7343C626-1B63-40FD-B1C3-FC90AF138FC9Q36307008-5C9D571E-4B12-4766-B219-D64CD2C1C6F6Q36417384-18B89241-45BF-4DD6-886A-0119BF6338B9Q36605868-E0C79EBF-5362-4649-8507-4E6D48609B54Q36644667-2C7F7BF5-B8BB-4145-9676-C4ECD9F1596FQ36690141-D9BEF0BC-8357-4073-A696-841BDDC65826Q36944006-7BAAD7F5-3C86-4980-B4F7-BF73CF47F886Q37031501-D94FDAE8-873F-4CED-AB7F-369066BCE347Q37075256-2DAC048E-3672-4C51-863E-261E86F09F1AQ37076331-8E5A1893-1035-45FB-BF39-8412893EF8F7Q37188039-CF4C2D64-7306-43BA-B5AA-B41257747E6DQ37234673-1A69D4B1-8A28-410F-84C5-6AA2C782B25EQ37422679-071E9E56-82F4-48D7-B407-D2EB278B2C89Q37592262-CC4EFA0B-BB5B-452F-8B9A-D6BE498FC2D4Q37604385-974A9CB9-D10D-4372-8F1A-6800F753C65FQ37679511-5CBC8366-6B6B-4068-94B6-2AD962EBC855Q37700667-0ECF34A0-0A1F-4774-90C3-5AD606173DA4Q37997359-8A5114E6-BACA-4633-B97A-2351BE5F9584
P2860
Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Gene-specific effects of infla ...... A levels in human hepatocytes.
@ast
Gene-specific effects of infla ...... A levels in human hepatocytes.
@en
type
label
Gene-specific effects of infla ...... A levels in human hepatocytes.
@ast
Gene-specific effects of infla ...... A levels in human hepatocytes.
@en
prefLabel
Gene-specific effects of infla ...... A levels in human hepatocytes.
@ast
Gene-specific effects of infla ...... A levels in human hepatocytes.
@en
P2860
P356
P1476
Gene-specific effects of infla ...... NA levels in human hepatocytes
@en
P2093
Alison E Aitken
P2860
P304
P356
10.1124/DMD.107.015511
P577
2007-06-18T00:00:00Z